TrialClinical pharmacology in drug development2020

Pharmacokinetic Properties of Single and Multiple Doses of Ertugliflozin, a Selective Inhibitor of SGLT2, in Healthy Chinese Subjects.

Yinhua Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.